After experiencing another year of double digit growth, Omega Pharma has taken further steps to strengthen its management team within the UK and Ireland, with the announcement of new supply chain and marketing directors.
The move will strengthen Omega Pharma’s status as the number four consumer healthcare company in the UK, facilitating further brand expansion within its market leading categories, including the recently acquired smoking cessation brand NiQuitin and the newly launched entry into vitamins with Men’s Health Lab. Omega Pharma will also continue to place significant support behind its existing growth categories, such as weight management (XLS Medical), cough (Bronchostop) and pharmacy analgesics (Solpadeine).
Chrissy Blythin: supply chain director
The first of the appointments sees Chrissy Blythin takes on the role of supply chain director for Omega Pharma UK and Ireland. The former Nestlé food and beverage supply chain director brings with her over 20 years of experience within branded FMCG manufacture and supply chain, and a reputation for delivering superior business results within a challenging environment, along with exceptional customer service.
In this role, Blythin will drive Omega Pharma’s development of a customer centric supply chain, and build a team that is passionate and focussed on adding value and efficiency to the business
Blythin said: “This is an incredibly exciting opportunity within a company that is enjoying significant success. The current rate of business growth will enable us to accelerate our vision to deliver a world class supply chain that puts our customers at the heart of everything we do.”
“There are amazing opportunities with this new role and I’m delighted to be joining such a fast growing and innovative business. I look forward to supporting the vision of Omega Pharma to be the engine for growth for our customers in the UK.”
Holly Turner: marketing director
In addition to Blythin, Holly Turner joins Omega Pharma as Marketing Director for UK and Ireland. The former GSK consumer healthcare global marketing director has a strong track record of driving change and building healthcare brands.
Commenting on her new role, Turner said: “Omega Pharma has achieved unparalleled growth in the OTC market thanks to its excellence in customer partnerships, a uniquely strong innovation pipeline and considerable investment behind its brands.”
“In my new role I will take the marketing execution to the next level ensuring long-term brand equity and growth for Omega Pharma.”
Neil Lister, general manager UK and Ireland, said: “I am delighted to announce the appointment of both Chrissy and Holly to the UK & Ireland business. Chrissy brings with her a customer-centric focus enabling us to put customer service at the heart of everything we do. Holly is an experienced people leader within OTC Consumer Healthcare and brings in depth knowledge on key areas Omega Pharma is looking to develop such as; medical marketing, digital expertise and direct to consumer communications.”